All In MedTech

Company

Encore Medical

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Apr 21, 2022Equity$1.1M$2.5M9Rule 506(b)Agent: Cedar Point Capital, LLCCommissions $275KForm D ↗May 3, 2022

1 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
Encore Medical, Inc.
Headquarters
Eagan, Minnesota
Incorporated
Minnesota in 2017
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    5 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.

    No 5%+ shareholder filings, SBIR grants or venture investors found under the name Encore Medical.

    Latest FDA decisions

    The 8 newest of 38 since 2015.

    Search the Clearance Tracker

    37 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar
    • NCT05537753 · 500 participants (planned) · Start Jul 12, 2023 · Primary completion Apr 2026

      Device: Encore PFO closure device; FDA-approved PFO closure device · For: Patent Foramen Ovale; Cryptogenic Stroke

      Sites: Little Rock, Arkansas; La Jolla, California; Tampa, Florida · 8 sites in all

    21 more trials with a free account

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 23216100
    Jan 24216500
    Feb 24017100
    Mar 24115800
    Apr 24420300
    May 24221800
    Jun 24119200
    Jul 24315800
    Aug 24116510
    Sep 24015100
    Oct 24019000
    Nov 24012300
    Dec 24215400
    Jan 25118800
    Feb 25716600
    Mar 25314000
    Apr 25013800
    May 25318200
    Jun 25217700
    Jul 25118400
    Aug 25116900
    Sep 25115000
    Oct 25520800
    Nov 25118900
    Dec 25120900
    Jan 26015500
    Feb 26616700
    Mar 26625100
    Apr 26522900
    May 26121300
    Jun 26124800
    Jul 26018000
    Aug 26428101
    Sep 26126710
    Oct 26018600
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    7 more in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    188 more recall records with a free account

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.